TipRanks
Go Ultimate55% OFF

Surgery Partners (1SP) Stock Price & Analysis

1SP Stock Chart & Stats

€20.40€0.00(0.00%)
At close: 5:30 PM GMT+1
€12€131 Jun24 Jul
Day’s Range
EUR 20.20 - EUR 20.60
52-Week Range
EUR 9.80 - EUR 20.80
Previous Close
EUR 20.40
Volume
360
Average Volume (3M)
0
Market Cap
EUR 2.68B
Enterprise Value
EUR 7.80B
Total Cash (Recent Filing)
EUR 216.70M
Total Debt (Recent Filing)
EUR 4.02B
Price to Earnings (P/E)
―
Beta
1.10
Next Earnings
Nov 10, 2026 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Same-facility Revenue Growth

Consistent same-facility growth indicates that the existing network is generating greater revenue without relying solely on acquisitions. Rate gains, modest case growth, and higher revenue per case can support durable organic expansion across the core outpatient platform.

Physician Network Expansion

Physician recruiting strengthens the referral base that drives procedure volumes through Surgery Partners facilities. A growing physician network can improve utilization, deepen local market relationships, and provide a durable foundation for revenue growth across multiple specialties.

Portfolio Simplification And Debt Reduction

Selling the hospital assets and directing proceeds toward debt reduction should simplify the business around its short-stay surgical platform while improving financial flexibility. Lower leverage can reduce balance-sheet pressure and leave more capacity to fund core facilities and growth initiatives.

Bears Say

Elevated Leverage

High leverage remains a material constraint on the company’s financial flexibility. It increases sensitivity to operating volatility and interest costs, while limiting the capital available for expansion, acquisitions, and other strategic investments over the next several quarters.

Persistent Net Losses And Interest Burden

Improving operating performance has not yet translated into consistent bottom-line profitability. Persistent losses and substantial interest expense absorb cash that could otherwise strengthen the balance sheet or support growth, leaving earnings quality dependent on further operating improvement.

Declining Cash Conversion

Positive free cash flow is encouraging, but its sharp year-over-year decline indicates weaker cash conversion or greater spending needs. If this trend persists, internally generated funds may provide less support for debt reduction, investment, and resilience against operating pressures.

Surgery Partners News

1SP FAQ

What was Surgery Partners’s price range in the past 12 months?
Surgery Partners lowest stock price was €9.80 and its highest was €20.80 in the past 12 months.
What is Surgery Partners’s market cap?
Surgery Partners’s market cap is €2.68B.
When is Surgery Partners’s upcoming earnings report date?
Surgery Partners’s next earnings report is estimated for Nov 10, 2026 (not yet confirmed), which is in 8 days.
How were Surgery Partners’s earnings last quarter?
Surgery Partners released its earnings results on Aug 10, 2026. The company reported €0.09 earnings per share for the quarter, beating the consensus estimate of €0.052 by €0.038.
Is Surgery Partners overvalued?
According to Wall Street analysts Surgery Partners’s price is currently Overvalued.
Does Surgery Partners pay dividends?
Surgery Partners does not currently pay dividends.
What is Surgery Partners’s EPS estimate?
Surgery Partners’s EPS estimate is 0.10.
How many shares outstanding does Surgery Partners have?
Surgery Partners has 128,874,800 shares outstanding.
What happened to Surgery Partners’s price movement after its last earnings report?
Surgery Partners reported an EPS of €0.09 in its last earnings report, beating expectations of €0.052. Following the earnings report the stock price went up 2.256%.
Which hedge fund is a major shareholder of Surgery Partners?
Hedge funds hold Surgery Partners shares: the largest hedge-fund position in Surgery Partners is 1,670,567,548 shares, and hedge funds decreased their holdings by 1.8M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology